logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5145.produseast1
Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea | Journal Article / Research | MSF Science Portal
Journal Article
|Research

Feasibility of Xpert Ebola Assay in Médecins Sans Frontières Ebola Program, Guinea

Van der Bergh R, Chaillet P, Sow MS, Amand M, van Vyve C, Jonckheere S, Crestani R, Sprecher A, Van Herp M, Chua AC, Piriou E, Koivogui L, Antierens A
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
Rapid diagnostic methods are essential in control of Ebola outbreaks and lead to timely isolation of cases and improved epidemiologic surveillance. Diagnosis during Ebola outbreaks in West Africa has relied on PCR performed in laboratories outside this region. Because time between sampling and PCR results can be considerable, we assessed the feasibility and added value of using the Xpert Ebola Assay in an Ebola control program in Guinea. A total of 218 samples were collected during diagnosis, treatment, and convalescence of patients. Median time for obtaining results was reduced from 334 min to 165 min. Twenty-six samples were positive for Ebola virus. Xpert cycle thresholds were consistently lower, and 8 (31%) samples were negative by routine PCR. Several logistic and safety issues were identified. We suggest that implementation of the Xpert Ebola Assay under programmatic conditions is feasible and represents a major advance in diagnosis of Ebola virus disease without apparent loss of assay sensitivity.

Countries

Guinea

Subject Area

Ebola

Languages

English
DOI
10.3201/eid2202.151238
Published Date
01 Feb 2016
PubMed ID
26812466
Journal
Emerging Infectious Diseases
Volume | Issue | Pages
Volume 22, Issue 2
Issue Date
2016-02-01
Dimensions Badge